Advertisements


Atossa Genetics completes enrollment for Phase 2 study of Topical Endoxifen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Atossa Genetics (ATOS) CEO Steve Quay on Preliminary Results from Male Phase 1 Study of Topical Endoxifen Conference (Transcript)

Atossa Genetics (ATOS) CEO Steve Quay on Preliminary Results from Male Phase 1 Study of Topical Endoxifen Conference (Transcript).....»»

Category: topSource: seekingalphaSep 13th, 2018

Atossa Genetics opens enrollment in Phase 2 study of oral Endoxifen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 13th, 2018

Atossa Genetics opens Phase 2 study of topical endoxifen to treat MBD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 26th, 2018

Atossa completes all dosing, clinical visits in topical Endoxifen Phase 1 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 20th, 2018

Eyenovia completes patient enrollment in Phase 3 MIST-1 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 3rd, 2018

Celgene & Bluebird"s CAR T Therapy Study Completes Enrollment

Celgene (CELG) and partner bluebird complete enrollment in a phase II study for CAR T cell therapy candidate, bb2121 for patients with relapsed and refractory multiple myeloma. .....»»

Category: personnelSource: nytNov 28th, 2018

Deciphera completes enrollment in INVICTUS pivotal Phase 3 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 15th, 2018

Dermira completes patient enrollment for Phase 2b lebrikizumab study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 23rd, 2018

Savara completes enrollment of IMPALA Phase 3 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2018

XBiotech completes enrollment of phase 2 bermekimab study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 5th, 2018

Marinus Pharmaceuticals completes enrollment in Phase 2 Magnolia Study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 25th, 2018

XBiotech completes enrollment for Phase 2 bermekimab study for HS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 24th, 2018

Cocrystal Pharma completes patient enrollment in Phase 2a CC-31244 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 20th, 2018

Atossa Genetics says Endoxifen study met all objectives in preliminary results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Merrimack completes enrollment in Phase 2 study of NSCLC candidate MM-121

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 6th, 2018

Genfit completes enrollment of Phase 2a elafibranor study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 28th, 2018

Alnylam Completes Enrollment in Phase III Givosiran Study

Zacks.....»»

Category: topSource: redinewsAug 23rd, 2018

Alnylam Completes Enrollment in Phase III Givosiran Study

Alnylam Pharmaceuticals (ALNY) completes enrollment in the phase III ENVISION study ahead of schedule of its pipeline candidate, givosiran. Alnylam Pharmaceuticals.....»»

Category: smallbizSource: nytAug 22nd, 2018

Alnylam completes enrollment in ENVISION Phase 3 study of givosiran

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 21st, 2018

Eiger BioPharmaceuticals completes enrollment in Phase 2 PREVENT study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2018